Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: Early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective

Blood

Volumn 88, Issue 2, 1996, Pages 714-720

  Enright, Helen ^a,b   Davies, Stella M ^a   DeFor, Todd ^a   Shu, Xiao ^a   Weisdorf, Daniel ^a   Miller, Wesley ^a   Ramsay, Norms K C ^a   Arthur, Diane ^a   Verfaillie, Catherine ^a   Miller, Jeffrey ^a   Kersey, John ^a   McGlave, Philip ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CANCER RISK; CHILD; CHRONIC MYELOID LEUKEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 8944221180     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.2.714.bloodjournal882714     Document Type: Article

References (29)

1. Goldman JM, Apperly JF, Jones L, Marcus R, Goolden AM, Batchelor R, Hale G, Waldman H, Reid CD, Hows J, Gordon-Smith E, Catovsky D, Galton DAG: Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med 314:202, 1986
2. McGlave PB: Therapy of chronic myelogenous leukemia with bone marrow transplantation, in Champlin R (ed): Bone Marrow Transplantation. Boston, MA, Kluwer Academic, 1990, p 235
3. Thomas ED, Clift RA, Fefer A, Appelbaum FR, Beatty P, Bensinger WI, Buckner CD, Cheever MA, Deeg HJ, Doney K, Flournoy N, Greenberg P, Hansen JA, Martin P, McGuffin R, Ramberg R, Sanders JE, Singer J, Stewart P, Storb R, Sullivan K, Weiden PL, Witherspoon R: Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 104:155, 1986
4. Clift RA, Appelbaum FR, Thomas ED: Treatment of chronic myeloid leukemia by marrow transplantation. Blood 82:1954, 1993
5. McGlave P, Bartsch G, Anasetti C, Ash R, Beatty P, Gajewski J, Kernan NA: Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: Initial experience of the National Marrow Donor Program. Blood 81:543, 1993
6. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroncek D, Thomas ED, Blume KG: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593, 1993
7. McGlave PB, Beatty P, Ash R, Hows JH: Therapy of chronic myelogenous leukemia with unrelated donor bone marrow transplantation: Results in 102 cases. Blood 75:1728, 1990
8. Gamis AS, Haake R, McGlave P, Ramsay NKC: Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children. J Clin Oncol 11:834, 1993
9. Ely P, Miller WJ: BCR/ABL mRNA detection following bone marrow transplantation for chronic myelogenous leukemia. Transplantation 52:1023, 1991
10. Hughes TP, Morgan GJ, Martial P, Goldman JM: Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia. Role of polymerase chain reaction in predicting relapse. Blood 77:874, 1991
11. Roth MS, Antin JH, Ash R, Terry VH, Gotlieb M, Silver SM, Ginsberg D: Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood 79:276, 1992
12. Goldman JM, Gale RP, Horowitz MM, Biggs J, Champlin R, Gluckman E, Hoffmann R, Jacobsen S, Marmont A, McGlave P, Messner H, Rimm A, Rozman C, Speck B, Tura S, Weiner R, Bortin M: Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk of relapse associated with T-cell depletion. Ann Intern Med 108:806, 1988
13. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions following bone marrow transplantation in humans. Blood 75:555, 1990
14. Davies SM, Shu XO, Blazar BR, Filipovich AH, Kersey JH, Krivit W, McCullough J, Miller WJ, Ramsay NKC, Segall M, Wagner JE, Weisdorf DJ, McGlave PB: Unrelated donor bone marrow transplantation: Influence of HLA A and B incompatibility on outcome. Blood 86:1636, 1995
15. Perkins HA, Hansen JA: The U.S. National Marrow Donor Program. Am J Pediatr Hematol Oncol 16:30, 1994
16. Stroncek D, Bartsch G, Perkins HA, Randall BL, Hansen JA, McCullough J: The National Marrow Donor Program. Transfusion 33:567, 1993
17. Goldman JM, Szydlo R, Horowitz MM, Gale RP, Ash RC, Atkinson K, Dicke KA, Gluckman E, Herzig RH, Marmont A, Masaoka T, McGlave PB, Messner H, O'Reilly RJ, Reiffers J, Rimm AA, Speck B, Veum-Stone JA, Wingard JR, Zwaan FE, Bortin MM: Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood 82:2235, 1993
18. Clift RA, Buckner CD, Thomas ED, Bryant E, Anasetti C, Bensinger WI, Bowden R, Deeg HJ, Doney KC, Fisher LD, Hansen JA, Martin P, McDonald GB, Sanders JE, Schoch G, Singer J, Storb R, Sullivan KM, Witherspoon RP, Appelbaum FR: Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia. Blood 84:4368, 1994
19. Speck B, Bortin MM, Champlin R, Goldman JM, Herzig RH, McGlave PB, Messner HA, Weiner RS, Rimm AA: Allogeneic bonemarrow transplantation for chronic myelogenous leukaemia. Lancet 1:665, 1984
20. Biggs JC, Szer J, Crilley P, Atkinson K, Downs K, Dodds A, Concannon AJ, Avalos B, Tutschka P, Kapoor N: Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy. Blood 80:1352, 1992
21. Pichert G, Alyea EP, Soiffer RJ, Roy D-C, Ritz J: Persistence of myeloid progenitor cells expressing BCR/ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia. Blood 84:2109, 1994
22. Clift RA, Buckner D, Appelbaum FR, Bryant E, Bearman SI, Petersen FB, Fisher LD, Anasetti C, Beatty B, Bensinger WI, Doney K, Hill RS, McDonald GB, Martin P, Meyers J, Sanders J, Singer J, Stewart P, Sullivan KM, Witherspoon R, Storb R, Hansen JA, Thomas ED: Allogeneic bone marrow transplantation in patients with chronic myeloid leukemia in chronic phase: A randomized trial of two irradiation regimens. Blood 77:1660, 1991
23. Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA, Ringden O, Stone JA, Bortin MM: Identical-twin bone marrow transplants for leukemia. Ann Intern Med 120:646, 1994
24. Mackinnon S, Barnett L, Heller G, O'Reilly RJ: Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 83:3409, 1994
25. Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F, Pietryga D, Hansen R, Chitambar CR, Anderson T, Flomenberg N: Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood 83:1980, 1994
26. Chiang KY, Weisdorf DJ, Davies SM, Enright H, Kersey JH, McGlave PB, Miller W, Ramsay NKC, Steinbuch M, Wagner JE, Blazar BR: Outcome of second marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse. Bone Marrow Transplant 17:39, 1996
27. Porter DL, Roth MS, McGarigle C, Ferrara JL, Antin JH: Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 330:100, 1994
28. van Rhee F, Lin F, Cullis JO, Spencer A, Cross NCP, Chase A, Garicochea B, Bungey J, Barrett J, Goldman JM: Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 83:3377, 1994
29. Cullis JO, Schwarer AP, Hughes TP, Hows JM, Franklin I, Morgenstern G, Goldman JM: Second transplants for patients with chronic myeloid leukaemia after original transplant with T-depleted donor marrow: Feasibility of using busulphan alone for reconditioning. Br J Haematol 80:33, 1992